GIQuIC Automation of Pathology Results

Now from Miraca

Avoid hours of manual data entry! Miraca pathology results now can populate the pathology section of the GIQuIC form automatically if you use gGastro® from gMed, a Modernizing Medicine company, or ProVation® MD from Wolters Kluwer. How is this automation possible? Miraca delivers highly structured pathology results through enhanced interfaces with gMed and ProVation MD,.

gGastro Capabilities

Pathology results for colonoscopies will populate automatically in the GIQuIC form.

ProVation MD Capabilities

Pathology results for single colonoscopies will populate automatically in the GIQuIC form. Additionally, the ProVation MD Adenoma Detection Rate report for physicians can be created automatically.

If your practice participates in the GIQuIC registry, you can avoid hours of manual data entry. Contact Miraca to get started: Call 1.866.588.3280 or email MiracaTechnology@MiracaLS.com.

What is GIQuIC?

The GI Quality Improvement Consortium, Ltd.—GIQuIC—is a non-profit collaboration of the American College of Gastroenterology (ACG) and the American Society for Gastrointestinal Endoscopy (ASGE), providing a quality benchmarking registry. Physicians are participating by collecting and submitting data about their colonoscopies. Participation in GIQuIC enables practices and centers to participate in PQRS reporting in order to avoid penalties by the Centers for Medicaid and Medicare Services (CMS).

Miraca Life Sciences provides fee-based consulting services to help clients understand their options for quality reporting and how to embed quality reporting into their practice or center. Quality reporting such as via GIQuIC is required for participation in the CMS programs Value-Based Modifiers and Merit-Based Incentive Payment System (MIPS) as the industry goes to a pay-for-performance model.

Contact Miraca Life Sciences to learn how Miraca can assist your practice
Call 1.866.588.3280 or email MiracaTechnology@MiracaLS.com

Your dermatopathologists are awesome! It is a huge gift to have your pathologists working with me.
— Kimberly J. Wonderlich, MD,
Wonderlich Dermatology, Fairbanks, Alaska


READ MORE
Learn about Miraca's unmatched quality. We provide our clients with access to the highest quality AP services.

Recent News


November 30, 2016

Stelara® Now Available for Therapeutic Drug Monitoring from Miraca Life Sciences

IRVING, Texas, December 1, 2016 — Miraca Life Sciences, the largest U.S. independent anatomic pathology lab, has expanded its InformTx™ therapeutic drug monitoring service for drugs that treat inflammatory bowel disease (IBD) with the addition of Stelara (ustekinumab).

Miraca Life Sciences continues to perform therapeutic drug monitoring (TDM) for Remicade® (infliximab), Humira® (adalimumab), Cimzia® (Certolizumab pegol) and Entyvio® (vedolizumab). Since […]

Continue reading


August 10, 2016

Ten Research Projects from Miraca Life Sciences Accepted for ACG Conference

IRVING, Texas, August 10, 2016 — Ten research projects from the GI pathologists at Miraca Life Sciences, the nation’s largest independent anatomic pathology lab, have been accepted for presentation at the Annual Meeting of the American College of Gastroenterology (ACG), which will be held October 14–19 in Las Vegas.

Authors from Miraca Life Sciences are linked below to their profile […]

Continue reading


July 13, 2016

Miraca Life Sciences Launches Easy Way to Complete GIQuIC Pathology Section

IRVING, Texas, July 13, 2016 — Working with a leading vendor of gastroenterology software, Miraca Life Sciences, the nation’s largest independent anatomic pathology lab, now enables the pathology section of the GIQuIC form to populate automatically. Miraca Life Sciences’ structured diagnosis data and smart electronic interfaces facilitate this easier process, which improves the current approach of using free-form text for […]

Continue reading


Miraca Life Sciences Adds New Way to Complete GIQuIC Pathology Section and Automate ADR Tracking

IRVING, Texas, July 13, 2016 — Miraca Life Sciences, the nation’s largest independent anatomic pathology lab, has worked closely with Wolters Kluwer throughout its latest software release of ProVation® MD to automatically populate the pathology section of the GIQuIC form for single colonoscopies, which will save hours of time for clients. Miraca Life Sciences’ use of structured diagnostic terminology combined […]

Continue reading


June 16, 2016

Miraca Life Sciences Launches InformTx™ Therapeutic Drug Monitoring for Four Biologic Drugs, Including Firsts for the United States

IRVING, Texas, June 16, 2016 — Miraca Life Sciences, the nation’s largest independent anatomic pathology lab, has expanded into clinical pathology testing with its launch of InformTx therapeutic drug monitoring (TDM) for patients with inflammatory bowel disease (IBD). The InformTx assays measure both drug and anti-drug antibody levels for infliximab (trade name Remicade®), adalimumab (trade name Humira®), certolizumab (trade name […]

Continue reading